Merck Healthcare Pty Ltd. Suite 1, Level 1 Building B, 11 Talavera Road, Macquarie Park NSW 2113, Australia
Leaving Site Disclaimer
You are now leaving the Test Tailor Treat website. This link will take you to a website to which our Privacy
Policy does not apply. You are solely responsible for your interactions with that website.
Erbitux First Line
Merck Healthcare Pty Ltd (Merck) is providing this Test Tailor Treat (TTT) website as an aid for oncologists. This TTT website will facilitate in the testing of the patients’ tumour sample on the presence or absence of any RAS mutations to guide the oncologist to choose the appropriate therapy for the patient.
The data you provide will be de-identified for Merck personnel in Australia administering the site. Some data may be transferred to other areas within Merck in other countries for trending analysis. The transferred data will not include any patient identifiers you provide.
The patients’ uploaded clinical PDF report will not be accessible to Merck personnel. Access is limited to the requesting doctor and the molecular pathology that performed the RAS test, respectively.
All the data of the TTT will be stored on a secure server that is hosted by the website developer.
Merck will not disclose your personal information to anyone other than contractors who provide services and who are governed by agreements that require personal information to be protected appropriately, unless compelled or permitted by law to do so.
If you would like to know more about our privacy policies and procedures please refer to our website www.merck.com.au.